Patients diagnosed with NAFLD or NASH, in fact, showed increased gene and protein expression of CD36, when compared with healthy controls [24], demonstrating the important role of this transporter in lipid accumulation. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.